GO:0035556 intracellular signal transduction: Signaling Cascade, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035556 intracellular signal transduction describes the process by which a signal is passed to downstream components within the cell, activating them to propagate the signal and trigger a change in cell function or state.
• The term covers cascades such as TNF receptor I-mediated apoptosis, growth hormone signaling, and immune receptor pathways that rely on intracellular adaptors and kinases.
• Key protein families include TNF receptor-associated factors, cIAP1, MyD88, Tollip, calcineurin, and steroid receptors, which localize to distinct intracellular compartments to relay signals.
• Dysregulation of intracellular signal transduction is linked to cancer, inflammatory diseases, and neurological disorders, making it a major therapeutic target.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of signaling components in relevant cell types.
• High-throughput CRISPR library screening combined with bioinformatics can identify novel regulators of intracellular signaling cascades.
Description
Intracellular signal transduction (GO:0035556) is the biological process in which a signal received by a cell is transmitted to downstream components within the cell, which become activated and propagate the signal, ultimately triggering a change in the function or state of the cell. This process is fundamental to how cells respond to hormones, cytokines, growth factors, and stress, and it underlies nearly every aspect of cell biology, from proliferation and differentiation to apoptosis and immune defense. The QuickGO definition emphasizes that the signal is passed on to downstream components that become activated themselves, highlighting the sequential and amplifying nature of these cascades. Researchers study intracellular signal transduction to understand normal physiology and to identify therapeutic targets in diseases such as cancer, autoimmunity, and neurodegeneration. The pathway often involves receptor-proximal events, adaptor proteins, kinases, phosphatases, and transcription factors that shuttle between cytoplasm and nucleus. Because signaling is highly context-dependent, experimental models that manipulate individual components are essential for causal inference.
intracellular signal transduction At A Glance
| GO ID | GO:0035556 |
|---|---|
| GO term | intracellular signal transduction |
| Ontology | biological_process |
| Synonym | intracellular signaling cascade; intracellular signaling pathway; intracellular signal transduction pathway; signal transmission via intracellular cascade |
| Major function | Relay and amplify signals from receptors or sensors to downstream effectors, leading to changes in cell function or state |
| Definition source | QuickGO definition: The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
| Related processes | TNF receptor I-mediated apoptosis, growth hormone signaling, immune receptor signaling, steroid receptor signaling |
| Cellular locations | Cytoplasm, plasma membrane, nucleus, and other intracellular compartments |
What Is GO:0035556?
Intracellular signal transduction is the process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. It encompasses the molecular events that convert an initial stimulus into a cellular response, often through reversible protein modifications, conformational changes, and regulated protein-protein interactions. This term is distinct from intercellular signaling because it focuses on events inside the cell after a signal has been received.
Why Is intracellular signal transduction Important in Cell Biology?
Intracellular signal transduction is central to virtually all cellular decisions, including survival, proliferation, differentiation, and death. Defects in these pathways cause or contribute to major human diseases such as cancer, chronic inflammation, and neurodegenerative disorders. Understanding the precise molecular steps allows researchers to design targeted interventions, and CRISPR-based models provide powerful tools to test causality and identify new drug targets.
• Controls cell fate decisions including apoptosis, survival, and proliferation.
• Mediates responses to growth hormone and other endocrine signals.
• Regulates immune and inflammatory responses through adaptors like MyD88 and Tollip.
• Involved in steroid hormone signaling and nuclear receptor function.
• Dysregulated in cancers, where anti-apoptotic signaling promotes tumor survival.
• Targeted by immunosuppressive drugs that inhibit calcineurin signaling.
• Essential for neuronal function and implicated in neurodegeneration.
• Provides a rich source of drug targets for precision medicine.
• Enables synthetic biology approaches to rewire cellular behavior.
• Requires sophisticated models to dissect context-dependent effects.
What Happens During intracellular signal transduction?
Signal reception and receptor-proximal events
In simple terms: A signal molecule binds to a receptor, which changes shape and starts a chain reaction inside the cell.
Intracellular signal transduction begins when a receptor or sensor receives a signal. For example, TNF receptor I engagement leads to the formation of a membrane-proximal signaling complex that includes TRADD, RIP1, and TRAF2, setting the stage for downstream events. Growth hormone binding to its receptor triggers intracellular signaling through JAK-STAT and other pathways. In immune cells, MyD88 and Tollip act as intracellular adaptors that relay signals from Toll-like receptors. These early events are often mediated by protein-protein interactions and post-translational modifications.
Amplification and propagation through kinase cascades
In simple terms: The initial signal is amplified by a series of enzymes that activate each other, like a domino effect.
After receptor activation, downstream kinases and phosphatases propagate and amplify the signal. For instance, in TNF receptor I-mediated apoptosis, the initial complex transitions to a cytoplasmic complex that activates caspase-8, leading to apoptosis. Growth hormone signaling involves JAK2 activation and STAT phosphorylation. Calcineurin, a phosphatase, is targeted to the plasma membrane by palmitoylation, where it regulates phosphatidylinositol 4-kinase and downstream signaling. These cascades often involve reversible phosphorylation and conformational changes.
Second messengers and compartmentalization
In simple terms: Small molecules and ions act as messengers that carry the signal to different parts of the cell.
Intracellular signal transduction frequently uses second messengers such as calcium, cAMP, and inositol lipids. Calcineurin is recruited to the plasma membrane via palmitoylation, where it interacts with the phosphatidylinositol 4-kinase complex, illustrating how compartmentalization regulates signaling. Steroid receptors can localize to different intracellular compartments, including the nucleus, to modulate gene expression. Actin-binding channels may also influence ion flux and signaling.
Nuclear translocation and transcriptional responses
In simple terms: The signal reaches the nucleus, where it turns genes on or off, changing the cell's behavior.
Many signaling pathways culminate in the activation of transcription factors that translocate to the nucleus. For example, corticosteroid receptors are intracellular receptors that, upon ligand binding, move to the nucleus and regulate gene transcription. Growth hormone signaling activates STAT proteins that dimerize and enter the nucleus to control gene expression. In TNF signaling, NF-kB activation leads to expression of anti-apoptotic genes, while cIAP1 ubiquitination regulates NF-kB and cell survival. These transcriptional changes ultimately alter cell function or state.
Feedback and termination
In simple terms: The cell has brakes to stop the signal once it has done its job.
Signal transduction is tightly regulated by negative feedback mechanisms. cIAP1, for example, is a ubiquitin ligase that can target itself and other signaling proteins for degradation, thereby limiting NF-kB activation. Tollip acts as an inhibitory adaptor that dampens TLR signaling. Phosphatases such as calcineurin reverse phosphorylation events, contributing to signal termination. These feedback loops prevent excessive or prolonged signaling that could lead to disease.
Key Genes Involved in GO:0035556 intracellular signal transduction
The following genes and proteins are central to intracellular signal transduction, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TNFRSF1A | TNF receptor I; initiates apoptosis and NF-kB signaling | Model for receptor-proximal signaling complexes |
| TRADD | Adaptor in TNF receptor I signaling | Component of complex I and II in apoptosis |
| RIPK1 | Kinase in TNF signaling; regulates apoptosis and necroptosis | Key node in cell fate decisions |
| TRAF2 | E3 ligase; activates NF-kB and JNK | Modulates TNF-induced signaling |
| CASP8 | Initiator caspase; activates apoptosis | Effector of TNF-induced apoptosis |
| GHR | Growth hormone receptor; activates JAK-STAT | Model for endocrine signaling |
| JAK2 | Tyrosine kinase; phosphorylates STATs | Central to growth hormone signaling |
| STAT5 | Transcription factor; mediates growth hormone effects | Readout of JAK-STAT pathway |
| NR3C1 | Glucocorticoid receptor; nuclear receptor | Intracellular localization and signaling |
| MYD88 | Adaptor in TLR/IL-1R signaling | Innate immune signal transduction |
| TOLLIP | Inhibitory adaptor in TLR signaling | Negative regulation of MyD88-dependent pathways |
| PPP3CA | Calcineurin A catalytic subunit | Calcium-dependent phosphatase in signaling |
| PPP3R1 | Calcineurin B regulatory subunit | Regulates calcineurin activity |
| PI4KA | Phosphatidylinositol 4-kinase alpha | Interacts with calcineurin at plasma membrane |
| BIRC2 | cIAP1; E3 ubiquitin ligase | Regulates NF-kB and cell survival |
| BIRC3 | cIAP2; E3 ubiquitin ligase | Modulates TNF signaling |
| ACTB | Actin; cytoskeletal component | Actin-binding channels and signaling |
How Is intracellular signal transduction Regulated?
Intracellular signal transduction is regulated at multiple levels, including post-translational modifications such as phosphorylation, ubiquitination, and palmitoylation. For example, palmitoylation targets calcineurin to the plasma membrane, where it regulates phosphatidylinositol 4-kinase. cIAP1 is a ubiquitin ligase that controls its own stability and that of other signaling proteins, thereby modulating NF-kB activation. Tollip acts as a negative regulator of TLR signaling by inhibiting MyD88-dependent pathways. Steroid receptors are regulated by ligand binding and intracellular localization. These regulatory mechanisms ensure appropriate signal strength and duration.
intracellular signal transduction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BIRC2 | Cancer; NF-kB-driven survival | Knockout in cancer cell lines to assess apoptosis |
| MYD88 | Inflammatory diseases; innate immunity | Knockout in macrophages to study TLR signaling |
| PPP3CA | Autoimmune diseases; immunosuppression | Point mutation to alter calcineurin activity |
| NR3C1 | Metabolic and inflammatory disorders | Knock-in of ligand-binding domain mutations |
| TNFRSF1A | Autoinflammatory syndromes | Knockout in fibroblasts to study TNF-induced apoptosis |
Cancer
Dysregulated intracellular signal transduction contributes to cancer through aberrant activation of survival and proliferation pathways. TNF receptor I signaling can promote either apoptosis or NF-kB-mediated survival depending on the context, and cIAP1 overexpression can shift the balance toward survival, contributing to tumorigenesis. Targeting these pathways is a major therapeutic strategy.
Inflammatory and autoimmune diseases
MyD88 and Tollip are critical regulators of innate immune signaling, and their dysfunction is linked to chronic inflammation and autoimmune conditions. Calcineurin signaling is targeted by immunosuppressive drugs in transplantation and autoimmune diseases.
Neurological disorders
Intracellular signal transduction pathways, including those involving actin-binding channels and steroid receptors, are important for neuronal function and survival. Disruption of these pathways may contribute to neurodegeneration.
From intracellular signal transduction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of cIAP1 sensitize cells to TNF-induced apoptosis? | CRISPR knockout of BIRC2 in HeLa or MEF cells |
| How does calcineurin palmitoylation affect its localization? | Point mutation of palmitoylation site in PPP3CA |
| What is the role of MyD88 in TLR signaling? | Knockout of MYD88 in macrophages |
| Can a specific STAT5 mutation alter growth hormone response? | Knock-in of STAT5 point mutation in hepatocytes |
| How does Tollip inhibit TLR signaling? | Overexpression of TOLLIP in HEK293 cells |
| What is the effect of glucocorticoid receptor nuclear localization? | Tagged knock-in of NR3C1 with GFP |
How to Study the intracellular signal transduction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Identify essential signaling components |
| Point mutation knock-in | Effect of specific amino acid changes | Study post-translational modifications |
| Tagged knock-in | Protein localization and dynamics | Track nuclear translocation |
| Overexpression | Gain-of-function effects | Rescue or sensitize cells |
| RNA-seq | Transcriptional changes | Downstream gene expression |
| Proteomics | Protein interactions and modifications | Map signaling complexes |
| Imaging | Subcellular localization | Visualize signaling events |
CRISPR knockout and point mutation
CRISPR-Cas9 knockout is widely used to delete genes involved in intracellular signal transduction, such as BIRC2 or MYD88, to assess their role in specific pathways. Point mutations can be introduced to study post-translational modification sites, such as calcineurin palmitoylation.
Knock-in and tagged reporters
Knock-in of fluorescent tags or epitope tags allows real-time tracking of signaling proteins. For example, tagging NR3C1 with GFP enables visualization of nuclear translocation. Knock-in of point mutations can model disease-associated variants.
Overexpression and rescue experiments
Overexpression of wild-type or mutant proteins, such as Tollip or cIAP1, can reveal gain-of-function effects and rescue phenotypes in knockout backgrounds.
High-throughput screening and bioinformatics
CRISPR library screens combined with RNA-seq and proteomics can identify novel regulators of intracellular signal transduction. Bioinformatics analysis of signaling networks helps prioritize candidates for functional validation.
How CRISPR Can Be Used to Study GO:0035556 intracellular signal transduction
Knockout
CRISPR knockout of genes such as BIRC2, MYD88, or TNFRSF1A can reveal their requirement in intracellular signal transduction pathways, including apoptosis and NF-kB activation.
Point Mutation
Point mutations can be introduced to study specific residues, such as the palmitoylation site of calcineurin, to determine their role in membrane targeting and signaling.
Knock-in
Knock-in of reporter tags or disease-associated alleles allows precise tracking of signaling proteins and modeling of human mutations.
Overexpression
Overexpression of signaling components like Tollip or cIAP1 can be used to study gain-of-function effects and to validate regulatory mechanisms.
How EDITGENE Supports intracellular signal transduction Research
Researchers studying intracellular signal transduction-related genes often need to determine whether a candidate gene is causally involved in a specific pathway or disease. EDITGENE provides comprehensive CRISPR-based services to enable such investigations with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for intracellular signal transduction research.
Frequently Asked Questions About intracellular signal transduction
What is intracellular signal transduction?
Intracellular signal transduction is the process in which a signal is passed on to downstream components within the cell, which become activated to further propagate the signal and trigger a change in cell function or state.
What genes are involved in intracellular signal transduction?
Key genes include TNFRSF1A, TRADD, RIPK1, TRAF2, CASP8, GHR, JAK2, STAT5, NR3C1, MYD88, TOLLIP, PPP3CA, PPP3R1, PI4KA, BIRC2, and BIRC3.
How is intracellular signal transduction regulated?
It is regulated by post-translational modifications such as phosphorylation, ubiquitination, and palmitoylation, as well as by feedback inhibitors like Tollip and cIAP1.
What diseases are associated with defective intracellular signal transduction?
Dysregulation is linked to cancer, inflammatory and autoimmune diseases, and neurological disorders.
What methods are used to study intracellular signal transduction?
Common methods include CRISPR knockout, point mutation knock-in, tagged knock-in, overexpression, RNA-seq, proteomics, and imaging.
How does TNF receptor I signaling lead to apoptosis?
TNF receptor I engagement forms a membrane-proximal complex that subsequently transitions to a cytoplasmic complex activating caspase-8, leading to apoptosis.
What is the role of calcineurin in intracellular signaling?
Calcineurin is a calcium-dependent phosphatase that is targeted to the plasma membrane by palmitoylation, where it regulates phosphatidylinositol 4-kinase and downstream signaling.
How does MyD88 function in signal transduction?
MyD88 is an adaptor protein that relays signals from Toll-like receptors to downstream kinases, activating NF-kB and inflammatory responses.
Can CRISPR be used to study intracellular signal transduction?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect signaling pathways.
What is the GO ID for intracellular signal transduction?
The GO ID is GO:0035556.
Conclusion
Intracellular signal transduction (GO:0035556) is a fundamental biological process that governs how cells respond to external and internal cues. Its dysregulation underlies numerous diseases, making it a prime target for therapeutic intervention. CRISPR-based models and high-throughput screening provide robust tools to dissect these pathways and identify new drug targets. EDITGENE offers comprehensive services to support such research, from knockout and knock-in cell models to library screening and bioinformatics.
References
- 1. Micheau O et al.. 2003. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.. Cell 114(2):181-90 PMID: 12887920
- 2. Campbell GS. 1997. Growth-hormone signal transduction.. J Pediatr 131(1 Pt 2):S42-4 PMID: 9255227
- 3. Ahima RS et al.. 1992. Intracellular localization of corticosteroid receptors in brain: potential interactions with signal transduction pathways.. Proc Soc Exp Biol Med 201(3):244-53 PMID: 1438340
- 4. Noda Y et al.. 2008. Actin-binding channels.. Prog Brain Res 170:551-7 PMID: 18655908
- 5. Zadoroznyj A et al.. 2022. Cytoplasmic and Nuclear Functions of cIAP1.. Biomolecules 12(2) PMID: 35204822
- 7. Ulengin-Talkish I et al.. 2021. Palmitoylation targets the calcineurin phosphatase to the phosphatidylinositol 4-kinase complex at the plasma membrane.. Nat Commun 12(1):6064 PMID: 34663815
- 8. Li YW et al.. 2015. Grouper (Epinephelus coioides) MyD88 and Tollip: intracellular localization and signal transduction function.. Fish Shellfish Immunol 42(1):153-8 PMID: 25449381
